AI IntelligenceFeb 13, 2026Secondary Market
Article
NLB (诺令生物)
Biotechnology firm Nanjing Nuoling Biotech (诺令生物) has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange (HKEX). CCB International (建银国际) is acting as the sole sponsor for the proposed listing process.
Data Cube AI EditorialSource: 36Kr
01
Source Brief
Biotechnology firm Nanjing Nuoling Biotech (诺令生物) has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange (HKEX). CCB International (建银国际) is acting as the sole sponsor for the proposed listing process.
02